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CD482 The Journal of Thoracic and CaObjective:Despite its theoretic advantage over saphenous vein grafts, the right gastro-
epiploic artery graft has not been accepted as the ideal conduit to revascularize the
right coronary artery. We therefore prospectively randomized these 2 grafts types
to compare their clinical, functional, and angiographic evolution at 6 months and
3 years.
Methods: From 2003 to 2006, 1397 consecutive patients underwent isolated revascu-
larization at the University of Louvain Medical School. Of this group, 370 patients
met the inclusion criteria for randomization and 66% of those were randomized.
The right coronary artery was revascularized with saphenous vein grafts in 116
patients and with right gastroepiploic arteries in 122 patients. All patients underwent
angiographic control 6 months postoperatively. The end points were major adverse
cerebrocardiovascular events and proportion of grafts patent or functional at
follow-up angiography.
Results: There were no significant differences between the 2 groups in terms of
hospital events. At follow-up there was no significant difference in major adverse
cerebrocardiovascular events between the 2 groups. At the 6-month angiographic
follow-up, 91% of the anastomoses in the right gastroepiploic artery group and
95% of the anastomoses in the saphenous vein graft group were controlled patent
(P 5 .92). In nonoccluded right coronary arteries, the proportion of patent grafts
was significantly lower and the proportion of nonfunctioning grafts was significantly
higher in the right gastroepiploic artery group than in the saphenous vein graft group.
Conclusion: There were no significant patency or major adverse cerebrocardiovascu-
lar events rate differences between the 2 groups; however, the number of functional
grafts was significantly higher in the saphenous vein graft group. Careful selection
of the coronary target is mandatory to obtain good results in gastroepiploic artery
grafting.
T
he ideal bypass conduit for the right coronary artery (RCA) remains a subject
of intense controversy. A variety of grafts and configurations are used: the
right gastroepiploic artery (RGEA),1 the right internal thoracic artery in situ
or in a Y-graft configuration,2 the free radial artery implanted into the aorta or the
left internal thoracic artery,3 and the saphenous vein graft (SVG).4
The influence of the type of graft to the RCA system on clinical results remains
poorly documented, and the complementary conduit of choice to this system has
yet to be determined. No superior long-term patency rate for any of these grafts to
the RCA has been clearly established.5 The patency rate of the right internal thoracic
artery to the RCA has been reported lower than that obtained when used for the leftrdiovascular Surgery c August 2008
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CDAbbreviations and Acronyms
GEA 5 gastroepiploic artery
RCA 5 right coronary artery
RGEA 5 right gastroepiploic artery
SVG 5 saphenous vein graft
coronary system.6 One evaluation of the SVG to the RCA ter-
ritory revealed good clinical and angiographic results after
long-term follow-up.4 The patency rates of radial arteries
and RGEAs are highly dependent on the degree of stenosis
of the native vessel, and their use remains limited because
of their association with a high risk of graft failure owing
to competitive flow.7
The RGEA was first described 20 years ago by Pym and
colleagues.8 Since then, its use has not increased as much
as that of the internal thoracic artery. Reasons for this less fre-
quent use include concerns about insufficient flow capacity
and vasospasm, the need to open the abdomen, a large vari-
ation in the artery size, and a patency result at 5 years identi-
cal to that of the SVG.9
Because of this controversy and our experience with the
RGEA (1500 grafts used since 1991), we decided to prospec-
tively randomize 2 grafts (RGEA and SVG) to revascularize
the RCA to evaluate their clinical, functional, and angio-
graphic results at 6 months and 3 years. This article reports
the midterm evaluation 6 months after randomization.
Materials and Methods
Study Design
All patients referred for isolated surgical coronary revascularization
fromApril of 2003 to November of 2006were screened according to
the inclusion criteria (Table 1). The patients who consented were
randomly assigned to undergo surgery according to 2 strategies:
RGEA to the posterior descending artery or SVG to the posterior de-
scending artery or posterolateral artery. Randomization was done
the day before the operation after inspection of the patients’ files
without having seen the preoperative angiogram. Complementary
grafting to the left coronary system was realized with either bilateral
internal thoracic arteries or an SVG depending on the location of the
targeted coronary vessel and the surgeon choice. All patients were
scheduled for a systematic angiography at 6 and 36months after sur-
gery. All patients gave written informed consent at the time of by-
pass surgery and before the angiographic investigation. The study
protocol was approved by the ethics committee of the University
of Louvain Medical School.
Patients
From 2003 to 2006, 1397 consecutive patients underwent isolated
bypass surgery at the University of Louvain Medical School. Of
those, 370 patients (26%) met the inclusion criteria for study enroll-
ment, and 244 (66%) of the 370 patients were actually randomized.
The remaining patients were not randomized because of 1) refusal of
systematic angiographic control (n 5 95) and 2) logistic incapacity
to randomize patients (n 5 31). RGEA grafting was performed inThe Journal of Tho122 patients, and SVG grafting was performed in 116 patients.
Six patients initially allocated to the SVG group were excluded
for protocol violation. In these cases, the surgeon decided to deviate
from the assigned revascularization strategy in favor of the RGEA
(Figure 1). Patients’ basal demographics and clinical characteristics
are shown in Table 2. The grafts were harvested and grafted as pre-
viously described.10,11 The operative characteristics are detailed in
Table 3.
Postoperative Management and Follow-up
Patients received prophylactic low-dose fractionated heparin post-
operatively and 160 mg of aspirin daily starting on postoperative
day 2. Treatment with vasoconstrictor agents was avoided whenever
possible. Patients were interviewed by telephone at 3 months, 6
months, and twice yearly thereafter. If the patient had been hospital-
ized between interviews, inpatient records were obtained. Patients
had a systematic stress test on a cycloergometer twice per year
performed under the supervision of their referring cardiologist.
Systematic angiographic follow-up was performed 6 months
after surgery. Isosorbide dinitrate (2 mg) was injected into each graft
before filming to avoid any spasm caused by the catheterization. At
least 2 orthogonal views of each internal thoracic artery graft were
obtained, with continued exposure as required to visualize the distal
runoff and size of the target coronary bed.
Data Analysis
The angiographic end point was the proportion of grafts that were
patent or functioning at follow-up angiography. Graft patency was
categorized in 3 patency grades: patency grade 0 5 not patent (ab-
sence of visible opacification by the graft of the target coronary ves-
sel; Thrombolysis InMyocardial Infarction flowgrade 0 in the graft);
patency grade 15 balanced or patent but not functioning: when the
flow from the native coronary artery is dominant or when flow sup-
ply from the native coronary and from the graft is balanced (Throm-
bolysis In Myocardial Infarction flow grade 1 or 2 in the graft);
patency grade 2 5 fully patent (complete opacification of the tar-
geted coronary vessel by the graft (Thrombolysis In Myocardial
TABLE 1. Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
 Angiographic evidence of
severe coronary stenosis
(.70% by visual estimate)
History of upper abdominal
surgery
 Elective procedure  History of upper
gastrointestinal bleeding,
active gastric or duodenal
ulcus.
 Isolated CABG  Body mass index .35
 Age ,75 y and life
expectancy .5 y
 Reoperation
 Cirrhosis
 Other configuration than
RGEA . PDA
SVG . PDA or PLA
CABG, Coronary artery bypass surgery; RGEA, right gastroepiploic artery;
PDA, posterior descending artery; SVG, saphenous vein graft; PLA, postero-
lateral artery.racic and Cardiovascular Surgery c Volume 136, Number 2 483
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CD116 received SVG
1297 Isolated CABG 03/2003 - 10/2006
370 Eligible
244 Randomized
126 Non Randomized
122 Randomized to SVG 122 Randomized to RGEA
122 received RGEA
6 patients excluded
for protocole violation
Follow-Up
Analysis
100% clinical + functional
87% angiographic
105 angiography analyzed
116 test analyzed
Allocation
100% clinical + functional
87% angiographic
102 angiography analyzed
112 test analyzed
Figure 1. Consort flow chart of the study. CABG,
Coronary artery bypass surgery; RGEA, right gas-
troepiploic artery; SVG, saphenous vein graft.Infarction flow grade 3 in the graft). A graft was considered func-
tional when in patency grade 2 and not functional when in patency
grade 0 or 1.
All postoperative angiograms were independently reviewed by 2
investigators; discrepancies in patency definition were reviewed by
a third investigator and resolved by consensus. Clinical end points
were the occurrence of major adverse cerebrocardiovascular events
and defined as a combined end point including death from any cause,
perioperative myocardial infarction (.30 days), late myocardial in-
farction (occurring between 31 days and 6 years), additional cardiac
surgery, coronary angioplasty, and neurologic events. Myocardial
infarction was defined as apparition of a Q wave or an increase of
more than 10 ng/mL of troponin I.
Statistical Analysis
We calculated that the enrollment of at least 244 patients would pro-
vide the study with 80% power to detect a relative reduction of 10%
in the rate of graft occlusion, from an estimated 15% with the SVG
grafting to 5% with RGEA, assuming a 20% within-patient correla-
tion for graft occlusion, a 2-tailed test, and an alpha value of 0.05.
Data are expressed as mean 6 1 standard deviation. In bivariate
analyses, the association of independent variables with each out-484 The Journal of Thoracic and Cardiovascular Surgery c Aucome variables was tested with the Student t test for independent
samples (binary variables).
All P values are 2-tailed. The Statistical Analysis Software (SAS,
9.1 release, SAS Institute Inc, SAS Campus Drive, Cary, NC) was
used in the statistical analysis.
Results
All patients were analyzed on an intention-to-treat basis.
The total number of graft anastomoses performed to revas-
cularized the RCA in each patient was similar in both
groups (Table 3).
In-hospital Events
Four patients died during hospitalization (4 in the SVG group
and none in the RGEA group, (P 5 .1). The first patient un-
derwent reoperation because of ischemia 4 hours after admis-
sion to the intensive care unit; all thoracic grafts were
doubled with an SVG, and a left ventricular assist device
was implanted. This patient died of multiple organ failure
on day 8. The second patient underwent reoperation forgust 2008
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CDmediastinitis on day 8 and died of multiple organ failure after
multiple abdominal operation for necrotico-hemorrhagic
pancreatitis on day 83. The third patient died suddenly on
day 5 on the ward, and the fourth patient underwent reopera-
tion for mediastinitis on day 9 and died of cardiogenic choc
on day 62 after a massive gastrointestinal hemorrhage. There
were no significant differences in the rate of stroke or infarc-
tion between the 2 groups (Table 4).
Clinical Follow-up
Clinical follow-up is 100% complete with a mean follow-up
of 20.1 6 11.7 months in the SVG group and 21.8 6 11.9
months in the RGEA group (P 5 .8). There were no late
deaths at follow-up. Three patients in the SVG group and
2 patients in the RGEA group had a recurrence of angina dur-
ing follow-up (P 5 .9). All of these patients had positive
stress test results and underwent a repeated recatheterization.
Of these, 1 patient had an occlusion of the graft (RGEA
group) and 4 patients had a progression of disease (3 patients
in the SVG group and 1 patient in the RGEA group). The
progression of the disease appeared on the posterior descend-
ing artery in 2 patients (all in the SVG group, 6 and 26
months postoperatively) and on the LAD in 2 patients (1 pa-
tient in the SVG group and 1 patient in the RGEA group 20
months postoperatively). They all underwent a percutaneous
coronary intervention of the new lesion. One last patient in
the RGEA group underwent percutaneous coronary interven-
tion of the RCA after the occlusion of the RGEA (26 months
postoperatively).
TABLE 2. Basal demographic and clinical characteristics
RGEA
n 5 122 (%)
SVG
n 5 116 (%) P value
Male 106 (87%) 98 (84%) .73
Mean age (y) 61.8 6 8.3 63.2 6 7.7 .2
Hypertension 87 (71%) 93 (80%) .15
Smokers 60 (49%) 47 (40%) .22
Diabetic 28 (23%) 24 (21%) .79
High cholesterol 92 (75%) 83 (72%) .59
Previous infarction 37 (30%) 42 (36%) .4
Inferior 25 (20%) 22 (19%) .89
Obesity (BMI . 30) 52 (43%) 54 (47%) .63
Peripheral vascular disease 11 (9%) 15 (13%) .44
Mean euroSCORE (additive) 2.5 (2.5) 2.8 (2.6) .19
Left ejection fraction ,30% 6 (5%) 2 (2%) .31
No. of 3-vessel disease 100 (82%) 112 (97%) ,.001
RCA stenosis mean % stenosis 90 6 10 88 6 11 .11
Location of the stenosis
RCA 92 (75%) 87 (75%) .93
PDA 27 (22%) 27 (23%) .95
PLA 3 (3%) 2 (2%) .95
BMI, Body mass index; PDA, posterior descending branch; PLA, posterior
lateral branch; RCA, right coronary artery.The Journal of ThoNo patient underwent redo cardiac surgery between hospi-
tal discharge and follow-up. Two patients in the RGEA group
had a stroke 14 and 31 months postoperatively (P 5 .5).
Functional Follow-up
Functional follow-up is 100% complete with a mean follow-
up of 17.8 6 8.4 months in the SVG group and 18.7 6 11.2
months in the RGEA group (P5 .8). Stress test results were
positive for ischemia in all 5 symptomatic patients described
above (3 patients in the SVG group and 2 patients in the
RGEA group; P 5 .9). All other patients had negative stress
test results. Mean exercise duration and maximal workloads
were similar in the SVG group compared with the RGEA
group (125 6 25 vs 130 6 30 Watts; P 5 .8).
Angiographic Follow-up
Overall patency. Angiographic follow-up was obtained in
102 patients (88%) in the SVG group and 105 patients (86%)
in the RGEA group (P5 .8) with a mean follow-up of 6.36
0.6 months and 6.1 6 0.7 months, respectively (P 5 .8).
Withdrawal of consent by 37 patients was the main reason
for this incomplete 6 months of angiography control.
One asymptomatic patient in the RGEA group had an oc-
clusion of the RGEA grafted onto the dominant right coro-
nary artery at the angiographic follow-up. The RCA was
dilated during the systematic control procedure.
In regard to patency grades, 14 grafts were not patent (pa-
tency grade 0: 9 in the RGEA group and 5 in the SVG group;
P 5 .4), 13 grafts were balanced (patency grade 1: 13 in the
RGEA group and 0 in the SVG group; P 5 .001), and 180
grafts were fully patent (patency grade 2: 83 in the RGEA
group and 97 in the SVG group; P 5 .001).
TABLE 3. Operative characteristics
RGEA
n 5 122
SVG
n 5 116 P value
No. of anastomoses per graft to the RCA
RGEA
PDA 122 0
SVG 12 116
PLA 12 24
PDA 105
Total anastomoses for
RCA territory
144/122 140/116 .96
Mean anastomoses for
RCA territory per
patient
1.2 1.2
Other operative characteristics
Off-pump procedure 9 8 .91
PDA, Posterior descending artery; PLA, posterolateral artery; CPB, cardio-
pulmonary bypass; IABP, intra-aortic balloon pump; RCA, right coronary
artery; RGEA, right gastroepiploic artery; SVG, saphenous vein graft.racic and Cardiovascular Surgery c Volume 136, Number 2 485
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the RGEA group and 97 (95%) in the SVG group (P 5 .4).
The functioning graft rate (grade 2) was 83 (79%) in the
RGEA group and 97 (95%) in the SVG group (P 5 .001).
Influence of RCA stenosis on graft patency. a) Occluded
RCA: There was no difference between the 2 groups in
the proportion of grafts with a patency grade of 0, 1, or 2
(Table 5). b) RCA stenosis between 80% and 99%: There
was no difference between the 2 groups in the proportion
of grafts with a patency grade of 0 or 2, but the proportion
of grafts with a patency grade of 1 was significantly higher
in the RGEA group then in the SVG group. c) RCA stenosis
less then 80%: The proportions of grafts with a patency
grade of 0 or 1 were higher in the RGEA group than in
the SVG group; the difference reached significance only
for the grafts with a patency grade of 1. Conversely, the
proportion of fully patent grafts (patency grade 2) was sig-
nificantly higher in the SVG group than in the RGEA
group.
The proportion of RGEA grafts in grade 1 increased when
the stenosis was less critical, but not significantly (15% for
stenosis 80%–99% vs 32% for stenosis , 80%; P 5 .4).
The proportion of nonfunctioning grafts (patency grade
01 1) in the SVG group did not increase with a less stenosed
RCA (7% for a stenosis of 100% vs 2% for a stenosis of 80%
to 99% vs 10% for a stenosis of ,80%; P 5 .3), whereas it
increased significantly in the RGEA group (2% for a stenosis
of 100% vs 18% for a stenosis of 80%–99% vs 68% for a ste-
nosis of ,80%; P 5 .001).
The evolution of left ventricular ejection fractions from
the preoperative measurement to the 6-month control was
minimal and similar for the 2 groups (61.5% 6 11.5% to
62.7% 6 12% in the RGEA group vs 62.2% 6 10% to
63% 6 11.5% in the SVG group; P 5 .8).
TABLE 4. Hospital events
RGEA
n 5 122 (%)
SVG
n 5 116 (%) P value
Mortality 0 4 (3%) .11
Reoperation 4 (3%) 6 (5%) .68
Bleeding 3 (2%) 3 (3%)
Sternum 1 (1%) 2 (2%)
Ischemia 0 1 (1%)
ICU stay (d) 1.7 6 6.9 2.1 6 7.8 .11
Morbidity
Acute myocardial infarction 1 (1%) 0 .98
Pulmonary infection 22 (18%) 16 (14%) .47
Stroke 1 (1%) 2 (2%) .96
Arrhythmia 25 (20%) 27 (23%) .71
Acute renal insufficiency 3 (3%) 5 (4%) .66
Postoperative hospital stay (d) 9 6 7 10 6 9.2 .16
RGEA, Right gastroepiploic artery; SVG, saphenous vein graft; ICU, intensive
care unit.486 The Journal of Thoracic and Cardiovascular Surgery c AuDiscussion
In this large prospective, randomized, single-center clinical
trial, no significant clinical difference was observed between
the 2 types of graft revascularization at midterm follow-up,
although angiographic evaluation demonstrated a signifi-
cantly higher proportion of functional SVGs compared
with RGEAs. The percentage of functioning SVGs (95%)
as well as the percentage of functioning RGEA (98%) for
an occluded RCA compares favorably to previously reported
studies.1,12 The flow capacity of the RGEA and its sensibility
to flow competition13 could explain such difference in the
number of functional grafts.
The flow capacity of the RGEA and its sensibility to flow
competition could explain such a difference in the number of
functional grafts. Uchida and Kawaue14 studied this phenom-
enon and concluded that flow competition depends on 3 fac-
tors: the viability of the revascularized area, the degree of
proximal stenosis, and the location of stenosis. In our series
no differences could be evidenced between the 2 groups for
any of these factors. Another explanation could be the ana-
tomic differences between the gastroepiploic artery (GEA)
and the SVG. The aortocoronary SVG is under direct aortic
root pressure, whereas the GEA is a branch of the gastrodu-
odenal artery, which in turn diverges from the common he-
patic artery and thus is the fourth branch of the abdominal
aorta. Because coronary blood supply is determined by a pres-
sure gradient between the aorta and the left ventricle, the driv-
ing pressure of the GEA could be lower than that of the SVG.
Shimizu and colleagues15 compared the RGEA and SVG
flow characteristic using a Doppler-tipped guidewire 1.6
years after CABG. They found that when coronary stenosis
is moderate, the flow volume of the RGEA was less than
that of the SVG. In contrast, the correlation between flow
in the SVG and severity of native coronary stenosis was
not significant in their series. They explained this difference
as the consequence of flow competition between the GEA
and the native coronary artery. The results of the present
study support these data: The proportion of nonfunctioning
grafts in the SVG group did not increase with the decrease
of the RCA stenosis, whereas it did in the RGEA group.
As it was the case in previous patency studies, our evaluation
of reperfusion is mainly based on angiographic flows ob-
served at rest in fasting patients. Previous studies16 have sug-
gested that eating could modify flow supply in the coeliac
circulation up to a point susceptible to influence myocardial
reperfusion after RGEA bypass surgery. In addition, physical
exercise, by increasing myocardial blood flow demand, could
modify flow status through a graft from a balanced status to
either predominantly native or graft dependent. Future stud-
ies evaluating the influence of changes in splanchnic and
myocardial flow conditions as those induced by a fat-rich
meat or by physical exercise are under way, which couldgust 2008
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RGEA, Right gastroepiploic artery; SVG, saphenous vein graft; PDA, posterior descending artery; PLA, posterolateral artery; RCA, right coronary artery.
Patency grades: 0 5 not patent; 1 5 balanced: patent but not functioning, when the flow from the native coronary artery is dominant or when flow supply
from the native coronary and from the graft is balanced; 2 5 fully patent.A
CDhelp to better understand the physiology of these revascular-
ization modalities.
Several technical methods have been proposed to increase
RGEA use, such as the skeletonization17 of the RGEA.
Indeed, Gagliardotto and colleagues17 have found several
potential benefits with RGEA skeletonization: The quality
evaluation of the graft and the sequential anastomoses can
be easier to carry out. Finally, limited periarterial dissection
may aid in preserving lymphatic and venous drainage to
the stomach and omentum. Another technique is the injection
of vasoactive drugs before grafting to increase flow and avoid
vasospasm.18,19 Ali and colleagues18 evaluated 3 calcium
channel blockers and papaverine in preventing RGEA spasm.
They concluded that papaverine, when given externally on
the perivascular fat of the RGEA, prevented graft spasm for
up to 2 hours, whereas verapamil proved to be the most
potent calcium channel blocker vasodilator.
The effect of randomization in this study eradicates the
bias of the coronary target selection for the choice of graft,
which is found in all of the retrospective studies mentioned.
In addition, the systematic angiographic evaluations at 6
months and 3 years are an essential part of a prospective eval-
uation of graft function as demonstrated by the fact that in
asymptomatic patients with negative exercise test results,
12% of the RGEAs were patent but not functioning at controlThe Journal of Thorangiography. An evaluation of graft patency or function
based on clinical symptoms or angiographic controls driven
by ischemic episodes could only provide a truncated vision
of the actual revascularization status of the patients.20
Several observations have demonstrated the capacity of
internal thoracic arteries21 or RGEAs22 to recover a function
at long term after having been found nonfunctional (string
sign) at early follow-up. This capacity seems related to endo-
thelial protection mechanisms that are probably absent in
SVGs. Because of the natural progression of the disease on
native vessels, this property could act in favor of RGEAs in
the longer term. The ongoing angiographic reevaluation of
the grafts at 3 years postoperatively could thus provide infor-
mation to clarify the meaning of these early findings, partic-
ularly in RGEA grafts with a balanced flow. At this stage of
follow-up, wemodified our indications for RGEA grafting on
the basis of these 6-month angiographic data. We now use
only RGEA grafts for RCAs that are suboccluded or oc-
cluded in patients aged less than 75 years, and we preferen-
tially use SVGs in older patients and in those with less
severely narrowed native coronary arteries.
Conclusions
No significant difference in terms of major adverse cerebro-
cardiovascular events or patency was found between the 2acic and Cardiovascular Surgery c Volume 136, Number 2 487
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CDgroups, but the number of functional graft was significantly
higher in the SVG group. Careful selection of the coronary
target is mandatory to obtain good results in RGEA grafting.
Three years of angiographic control is mandatory to evaluate
the long-term outcome of balanced RGEA grafts.
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